A radiocalibration method with pseudo internal standard to estimate circulating metabolite concentrations.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Bioanalysis

• Publication date

  2010-07-13

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4155/bio.10.81PMID 21083234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolites in Safety Testing: “MIST” for the Clinical Pharmacologist

  2010cited by this paper
• Overview of metabolite safety testing from an industry perspective.

  2010cited by this paper
• Quantifying the Metabolic Activation of Nevirapine in Patients by Integrated Applications of NMR and Mass Spectrometries

  2010cited by this paper
• Interpretation and considerations on the safety evaluation of human drug metabolites.

  2009cited by this paper
• Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment.

  2009cited by this paper
• Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.

  2009cited by this paper
• Predicting circulating human metabolites: how good are we?

  2009cited by this paper
• A holistic strategy for characterizing the safety of metabolites through drug discovery and development.

  2009cited by this paper
• Which human metabolites have we MIST? Retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development.

  2009cited by this paper
• Approaches to the assessment of stable and chemically reactive drug metabolites in early clinical trials.

  2009cited by this paper
• Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing.

  2009cited by this paper
• Clearing the MIST (metabolites in safety testing) of time: The impact of duration of administration on drug metabolite toxicity.

  2009cited by this paper
• Safety testing of metabolites: Expectations and outcomes.

  2009cited by this paper
• Metabolites in safety testing.

  2009cited by this paper
• Unique/Major Human Metabolites: Why, How, and When to Test for Safety in Animals

  2008cited by this paper
• Unique/major human metabolites: why, how, and when to test for safety in animals.

  2008cited by this paper
• Determination of relative response factors of impurities in paclitaxel with high performance liquid chromatography equipped with ultraviolet and charged aerosol detectors.

  2008cited by this paper
• A rapid method for quantitatively estimating metabolites in human plasma in the absence of synthetic standards using a combination of liquid chromatography/mass spectrometry and radiometric detection.

  2007cited by this paper
• Current opinion: safety evaluation of drug metabolites in development of pharmaceuticals.

  2007cited by this paper
• Metabolites and safety: What are the concerns, and how should we address them?

  2006cited by this paper
• Safety Assessment of Stable Drug Metabolites

  2006cited by this paper
• A regulatory perspective on issues and approaches in characterizing human metabolites.

  2006cited by this paper
• Safety assessment of drug metabolites: Characterization of chemically stable metabolites.

  2006cited by this paper
• Drug metabolites in safety testing.

  2002cited by this paper
• Identification and quantification of fluorine-containing metabolites of 1-chloro-2,2,2-trifluoroethane (HCFC133A) in the rat by 19F-NMR spectroscopy.

  1995cited by this paper
• Handbook of Analytical Derivatization Reactions

  1980cited by this paper

• Cross-industry demonstration of the validity of the mixed matrix method for the assessment of cross-species exposure coverage of human circulating drug metabolites.

  2025cites this paper
• The Current State of Biotransformation Science – Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends

  2024cites this paper
• A MIST conception: what has been learned from twenty years of human metabolite safety assessment?

  2023cites this paper
• Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group

  2023cites this paper
• Unequal Absorption of Radiolabeled and Nonradiolabeled Drug from the Oral Dose Leads to Incorrect Estimates of Drug Absorption and Circulating Metabolites in a Mass Balance Study.

  2019cites this paper
• Selective drug metabolite trace analysis by very high-volume injections and heartcut two-dimensional (2D)-ultrahigh performance liquid chromatography (UHPLC).

  2019cites this paper
• Development of a new method for the quantitation of metabolites in the absence of chemically synthetized authentic standards

  2019cites this paper
• Late-occurring and Long-circulating Metabolites of GABAAα2,3 Receptor Modulator AZD7325 Involving Metabolic Cyclization and Aromatization: Relevance to MIST Analysis and Application for Patient Compliance

  2018influential citation
• Standard-Free Bioanalytical Approach for Absolute Quantitation of Drug Metabolites Utilizing Biosynthesis of Reciprocal Radio and Stable Isotopologues and Its Application.

  2017cites this paper
• Microdosing, isotopic labeling, radiotracers and metabolomics: relevance in drug discovery, development and safety.

  2017cites this paper
• AZD 7325 involving metabolic cyclization and aromatization : relevance to MIST analysis and application for patient compliance

  2017cites this paper
• A decade of drug metabolite safety testing: industry and regulatory shared learning

  2017cites this paper
• Comparison of 19F NMR and 14C Measurements for the Assessment of ADME of BYL719 (Alpelisib) in Humans

  2017cites this paper
• UNDERSTANDING DRUG METABOLISM IN HUMANS

  2016cites this paper
• Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions—an Industry Perspective

  2016influential citation
• Regulatory Submission: MIST and Drug Safety Assessment

  2015cites this paper
• Themed issue on radioisotopic bioanalysis.

  2015cites this paper
• Analytical challenges for conducting rapid metabolism characterization for QIVIVE.

  2015cites this paper
• Mini FocuS iSSue : tieRed appRoach to BioanalySiS

  2014cites this paper
• Reflecting on a decade of metabolite screening and monitoring.

  2014cites this paper
• Application of a tiered approach to the validation of accelerator MS assays.

  2014cites this paper
• Data-driven approach for cross-species comparative metabolite exposure assessment: how to establish fundamental bioanalytical parameters for the peak area ratio method.

  2014cites this paper
• Hayes' Principles and Methods of Toxicology, Sixth Edition

  2014cites this paper
• A tiered approach to address regulatory drug metabolite-related issues in drug development.

  2014cites this paper
• Metabolism and Excretion of 6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine, an HSP90 Inhibitor, in Rats and Dogs and Assessment of Its Metabolic Profile in Plasma of Humans

  2013cites this paper
• Metabolism and Excretion of 6-Chloro-9-(4-methoxy-3, 5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine, an HSP90 Inhibitor, in Rats and Dogs and Assessment of Its Metabolic Profile in Plasma of Humans s

  2013cites this paper
• Activity-based exposure comparisons among humans and nonclinical safety testing species in an extensively metabolized drug candidate

  2013influential citation
• DMD054023 2133..2147

  2013cites this paper
• Identification of drug metabolites in human plasma or serum integrating metabolite prediction, LC-HRMS and untargeted data processing.

  2013cites this paper
• The early estimation of circulating drug metabolites in humans

  2012cites this paper
• Predicting Human Biotransformation Pathways

  2012cites this paper
• A Simple Liquid Chromatography-Tandem Mass Spectrometry Method to Determine Relative Plasma Exposures of Drug Metabolites across Species for Metabolite Safety Assessments (Metabolites in Safety Testing). II. Application to Unstable Metabolites

  2012cites this paper
• Use of relative 12C/14C isotope ratios to estimate metabolite concentrations in the absence of authentic standards.

  2012cites this paper
• Safety Testing of Drug Metabolites: A Practical Approach for the Implementation of the MIST Guidance in PKDM

  2012cites this paper
• Radiolabelled mass-balance excretion and metabolism studies in laboratory animals: are they still necessary?

  2012cites this paper
• Use of radiolabeled compounds in drug metabolism and pharmacokinetic studies.

  2012cites this paper
• Meeting the MIST regulations: human metabolism in Phase I using AMS and a tiered bioanalytical approach.

  2012cites this paper
• Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism

  2012cites this paper
• From definition to implementation: a cross-industry perspective of past, current and future MIST strategies

  2011cites this paper
• Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction.

  2011cites this paper
• Addressing MIST (Metabolites in Safety Testing): bioanalytical approaches to address metabolite exposures in humans and animals.

  2011cites this paper
• "As can be seen from the diverse selections of the editorial board and us, the senior editors, it is an almost impossible task to pick one single overall winner this year."

  2011cites this paper
• The best of Bioanalysis 2010

  2011cites this paper
• Welcome to MIST and bioanalysis. Foreword.

  2010cites this paper
• Overview of metabolite safety testing from an industry perspective.

  2010cites this paper
• A Simple Liquid Chromatography-Tandem Mass Spectrometry Method to Determine Relative Plasma Exposures of Drug Metabolites across Species for Metabolite Safety Assessments

  2010cites this paper
• Meeting Report Meeting Report: Metabolites in Safety Testing (mist) Symposium—safety Assessment of Human Metabolites: What's Really Necessary to Ascertain Exposure Coverage in Safety Tests?

  year unknowncites this paper